Caylee Raber is the Director of the Health Design Lab at Emily Carr University of Art + Design. Within this role, Caylee establishes and leads health design projects that bring together faculty and students with industry and community partners to improve health services and products through a human-centred design approach. This includes collaborations with Vancouver Coastal Health, Providence Health Care, Ministry of Health, Centre for Aging and Brain Health Innovation, BC Children’s Hospital and many other local start-ups and non-profit organizations. Caylee’s research interest lies in the use of co-design and participatory research methodologies as a way to support the improvement of health product, services and systems through a community and patient-centred focus. Within the lab, Caylee leads research projects related to quality improvement, hospital redevelopment, and service design using participatory and community-based research methodologies.
Dr. Gabe Kalmar
Dr. Kalmar has been an avid supporter of entrepreneurship in Canada for the past 25 years. Throughout his career, Dr. Kalmar has been engaged in strategic consulting activities with several early stage pharmaceutical companies which included overseeing operations, implementing technology development and providing merger and acquisition planning. A testament to this is the 12 years Dr. Kalmar spent supporting the strategic goals for Genome BC. He has taken on roles as the Executive Director of Operations, Vice President of Sector Development, and Vice President of Entrepreneurship and Commercialization. He was also the President and CEO of the Pacific Autism Family Network which has solidified its presence as a centre for excellence and a top tier support system for individuals with Autism Spectrum Disorder and their families in British Columbia. He is also on the board of a number of companies including MRMProteomics and HeadCheck Health. Dr. Kalmar holds a BSc in Biochemistry and MSc in Virology from the University of British Columbia, and received his PhD in Virology from Simon Fraser University.
BCIT MAKE+ and Product and Process Applied Research Team
Judy Findlay is an experienced biomedical engineer who leads projects at BCIT in the research, development and commercialization of new medical devices. She has a Master’s degree in applied science from UBC and an engineering degree from Carleton University. Judy’s work at BCIT in applied research has been interspersed with frequent and fruitful periods working directly for medical device companies to lead product development, design verification, design controls and quality systems, technical support of regulatory approvals, design transfer to manufacturing, process validation and Quality management
Judy's professional passion lies in helping advance new medical technologies from the idea stage through to market. She is delighted to be returning to Hatching Health this year as a first-round judge.
Dr. Leanne Currie
Professor at the School of Nursing at the University of British Columbia
Headshot and more description coming soon!
Dr. Michael Koehle
Dr. Koehle is the Director of the Division of Sport and Exercise Medicine at UBC. He is also a physiologist specialising in exercise, respiratory and environmental physiology. Dr. Koehle is an Associate Professor in both the School of Kinesiology and the Division of Sport and Exercise Medicine in the Department of Family Practice and the principal investigator for the environmental physiology lab at the University of British Columbia (UBC). Dr. Koehle did his clinical training at the University of Toronto and UBC, and various rural and remote locations around Canada and internationally. His research investigates the interaction between exercise and environmental stressors such as air pollution and high altitude.
Dr. Koehle is the Assistant Academic Director of the Office of Education Innovation, a new initiative by the Faculty of Medicine to develop innovative products in the education space. He has also worked as a consultant and executive in the private sector, and is a partner at FirstLine Venture Partners.
Dr. Robin Coope
Instrumentation Group Leader at the BC Cancer Agency
Headshot and more description coming soon!
Dr. Todd Farrell
Todd manages the University of British Columbia’s Seed Investment Fund. The Fund invests seed and pre-seed risk capital into high potential start-up companies that are associated with UBC. During his investment career Todd has seed funded 16 UBC ventures that have cumulatively attracted $350 million in follow on funding. He has also been the lead seed investor in three new ventures that subsequently went on to win BCTIA’s most promising start-up award. Todd has twenty years of venture capital experience working locally with GrowthWorks Capital, Vancity Capital and UBC. Todd is also an experienced entrepreneur having founded and managed his own spin-out company from a UK based research institution that was acquired by Thomson Reuters. Previous to this he worked for four years as a technology transfer manager at a set of research institutes as well as having worked as an assistant economist for the Forestry Commission in the UK. Todd studied both Science and Business as an undergraduate at UBC and received a MBA from University of Bath in England.
Dr. William Parker
Joule Innovation Council
Currently completing his Radiology Residency at the University of British Columbia, William Parker is passionate about the development of innovative technology to improve patient care and outcomes. He has previous experience as Chief Medical Officer for medical wearable device start-up, Salu Design Group, and currently designs and develops primary care clinical tools and devices with medical start-up RFX Corp. Dr. Parker is also a writer on health technology for the Medical Post, and previously for CMAJ Future Practice. Dr. Parker was part of the team that brought Hacking Health to Edmonton. Hacking Health is a conference that brings together health professionals, designers, engineers and business experts to identify and propose solutions to specific medical challenges. He was also a member of the Royal College Technology Task Force. Dr. Parker studied Cellular and Molecular Biology at the University of Victoria and holds a BSc in Medical Sciences from the University of Alberta.